Original Article

Liver Oxidant Stress Induced By Paracetamol Overdose

A Grypioti

Citation

A Grypioti. Liver Oxidant Stress Induced By Paracetamol Overdose. The Internet Journal of Pharmacology. 2005 Volume 4 Number 2.

Abstract

Acetaminophen (APAP, AAP) overdose can cause severe hepatotoxicity and even liver failure and hepatic centrilobular necrosis in experimental animals and humans. Despite substantial efforts over the last 30 years, the mechanism of APAP-induced liver cell injury is still not completely understood. In the initial phases of toxicity acetaminophen is metabolically activated by cytochrome P450 enzymes to a reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI) that depletes glutathione (GSH) and covalently bound to cellular proteins including a number of mitochondrial proteins. N-acetylcysteine has been currently used as antidote as it was shown that repletion of GSH prevented the toxicity. Although covalent binding has been shown to be an excellent correlate of toxicity, a number of other events have been shown to occur and are likely important in the initiation and repair of toxicity. Recent studies have demonstrated that nitrated tyrosine residues, induced by rapid reaction of superoxide and nitric oxide (NO), occur in the necrotic cells following toxic doses of acetaminophen. Also, NO synthesis is dramatically increased following acetaminophen overdose earning a role in controlling lipid peroxidation. In addition, the significance of cytokines and chemokines (IL-1α;, IL-10, macrophage inhibitory protein-2, monocyte chemoattractant protein-1) in the development of toxicity and repair processes has been demonstrated by recent studies. This review reconciles many of the controversial findings of the past and provides a viable hypothesis for the mechanism of hepatocellular injury after APAP overdose.

 

Introduction

Overdoses of the analgesic and antipyretic acetaminophen represent one of the most common pharmaceutical product poisonings in the United States today (1). Although considered safe at therapeutic doses, in overdose, acetaminophen produces a centrilobular hepatic necrosis that can be fatal (2). Whereas the initial biochemical and metabolic events that occur in the early stages of toxicity have been well described, the precise mechanisms of hepatocyte death are poorly understood. Necrosis is recognized as the mode of cell death and apoptosis has been ruled out (3, 4).

Several recent excellent reviews on acetaminophen toxicity have been recently published (5, 6). The following manuscript will review the role of covalent binding in toxicity as well as other factors recently identified that contribute to the toxicity. These factors include oxidative stress, nitrotyrosine formation, inflammatory cytokines, and the possible importance of mitochondrial permeability transition.

Metabolic Activation of Acetaminophen

The metabolism in acetaminophen toxicity is very important. Acetaminophen is metabolically activated by cytochrome P450 to form a reactive metabolite that covalently binds to protein (7). The reactive metabolite was found to be N-acetyl-p-benzoquinone imine (NAPQI), which is formed by a direct two-electron oxidation (8). More recently, the cytochromes 2E1, 1A2, 3A4, and 2A6 (9,10,11) have been reported to oxidize acetaminophen to the reactive metabolite. NAPQI is detoxified by glutathione (GSH) to form an acetaminophen-GSH conjugate. After a toxic dose of acetaminophen, total hepatic GSH is depleted by as much as 90%, and as a result, the metabolite covalently binds to cysteine groups on protein, forming acetaminophen-protein adducts (7).

Biochemical Mechanisms of Toxicity

Events that produce hepatocellular death following the formation of acetaminophen protein adducts are poorly understood. One possible mechanism of cell death is that covalent binding to critical cellular proteins results in subsequent loss of activity or function and eventual cell death and lysis. Primary cellular targets have been postulated to be mitochondrial proteins, with resulting loss of energy production, as well as proteins involved in cellular ion control (12). Tirmenstein and Nelson (13) and Tsokos-Kuhn et al. (14) reported alterations of plasma membrane ATPase activity following toxic doses of acetaminophen.

A number of proteins bound to acetaminophen have been isolated and identified. A review of the individual proteins that were isolated and identified by individual analysis has been published (15, 16). Subsequently, Qui et al. (17) used matrix-assisted laser desorption ionization mass spectrometry to identify 20 additional proteins containing covalently bound acetaminophen.

Although it is plausible that partial inhibition of a large number of enzymes may contribute to cell death, questions are generated relative to the validity of the hypothesis that covalent binding to critical proteins is the only mechanism of acetaminophen toxicity.

Loss of mitochondrial or nuclear ion balance has also been suggested to be a toxic mechanism involved in acetaminophen-mediated cell death since either of these losses can lead to increases in cytosolic Ca2+ concentrations, mitochondrial Ca2+ cycling, activation of proteases and endonucleases, and DNA strand breaks (12, 18, 19). The effect of the addition of NAPQI on isolated mitochondria has been reported (20) and inhibition of mitochondrial respiration has been investigated as an important mechanism in acetaminophen toxicity (21).

Early Research on Oxidative Stress

Oxidative stress is another mechanism that has been postulated to be important in the development of acetaminophen toxicity. Thus, increased formation of superoxide would lead to hydrogen peroxide and peroxidation reactions by Fenton-type mechanisms. It has been shown that NAPQI reacts very rapidly with GSH (k1 = 3.2 x 104 M-1 s-1 at pH 7.0) (22), and there are a number of potential mechanisms that have been suggested to play a role. Under conditions of NAPQI formation following toxic acetaminophen doses, GSH concentrations may be very low in the centrilobular cells, and the major peroxide detoxification enzyme, GSH peroxidase, which functions very inefficiently under conditions of GSH depletion (23), is expected to be inhibited. In addition, during formation of NAPQI by cytochrome P450, the superoxide anion is formed, with dismutation leading to hydrogen peroxide formation (24). Also, others have suggested that peroxidation of acetaminophen to the semiquinone free radical would lead to redox cycling between the acetaminophen and the semiquinone. This mechanism may lead to increased superoxide and toxicity (25).

A significant amount of evidence has pointed to the potential involvement of oxidative stress in acetaminophen toxicity. Nakae et al. (26) reported that administration of encapsulated superoxide dismutase decreased the toxicity of acetaminophen in the rat. Moreover, the iron chelator, deferoxamine, has been shown to decrease toxicity in rats (27). Schnellmann et al showed that deferoxamine caused a delay in the rate of development of acetaminophen toxicity in mice, but after 24 h, the relative amount of toxicity was not affected (28). These data suggest that an iron-catalyzed Haber-Weiss reaction may also play a role in the development of oxidant stress and injury.

Role of Kupffer Cells

Several laboratories have studied the role of macrophage activation (29) in acetaminophen toxicity. Kupffer cells are the phagocytic macrophages of the liver. When activated, Kupffer cells release numerous signaling molecules, including hydrolytic enzymes, eicosanoids, nitric oxide, and superoxide. Kupffer cells may also release a number of inflammatory cytokines, including IL-1, IL-6, and TNF-α (29), and multiple cytokines are released in acetaminophen toxicity (30, 31, 33, 34, 39). Laskin et al. (29) examined the role of Kupffer cells in acetaminophen hepatotoxicity by pretreating rats with compounds that suppress Kupffer cell function (gadolinium chloride and dextran sulfate). These investigators reported that rats pretreated with these compounds were less sensitive to the toxic effects of acetaminophen. Similar effects were reported in the mouse (30). Goldin et al. (35) showed that treatment of mice with liposomes containing dichloromethylene disphosphonate to knock out the Kupffer cells also decreased acetaminophen toxicity. Similarly, Hinson et al. reported that pretreatment of mice with gadolinium chloride or dextran sulfate decreased the toxic effects of acetaminophen (36). These studies suggested a critical role for Kupffer cells in the development of acetaminophen hepatotoxicity; however, recent work by Ju et al. (37) came to a different conclusion. They pretreated mice with gadolinium chloride and found that the number of Kupffer cells in the liver was only partially decreased. Consistent with previous reports, they showed decreased acetaminophen toxicity in the pretreated mice. However, treatment of mice with dichloromethylene diphosphonate completely depleted the liver of Kupffer cells, but toxicity was increased. These data raise questions relative to the importance of Kupffer cells in acetaminophen toxicity.

Nitrotyrosine and Acetaminophen Toxicity

Hinson et al recently showed that nitrotyrosine occurs in the centrilobular cells of the liver of acetaminophen-treated mice (38). Immunohistochemical analysis of liver of acetaminophen-treated mice indicated that nitration occurred in the same cells that contained acetaminophen adducts and developed necrosis (38). Nitrotyrosine was formed by a reaction of peroxynitrite with tyrosine. Nitration of tyrosine has been shown to be an excellent biomarker of peroxynitrite formation (39). It is formed by a rapid reaction between nitric oxide and superoxide, and Mayeux et al. found that NO synthesis (serum levels of nitrate plus nitrite) was increased in acetaminophen toxicity (38). Also, others reported the induction of hepatic iNOS in the acetaminophen-treated rat (40). NO and superoxide react to produce peroxynitrite (ONOO-) at a rate near the diffusion-controlled limit (7 x 109 M-1 s-1). Peroxynitrite is a species that not only leads to the nitration of tyrosine but is also a potent oxidant that can attack a wide range of biological targets (41), and under conditions of reduced cellular oxidant scavenging capability, peroxynitrite is highly toxic (42). The anion is relatively stable, but the acid rearranges to nitrate with a half-life of 1.9 s at pH 7.4; the pK is 7.5 (42). Oxidation reactions can involve one or two-electron processes. Oxidation of lipids (43), proteins, or DNA bases (41) has been reported. Thus, peroxynitrite is an excellent candidate for a toxic species. Moreover, it is normally detoxified by GSH/GSH peroxidase, and GSH is depleted in acetaminophen toxicity (44). GSH peroxidase is a key enzyme in this defense mechanism (45). Thus, a normal detoxification mechanism for peroxynitrite is impaired. Also, even though acetaminophen itself will detoxify peroxynitrite (46), the drug is metabolized rapidly in the mouse and concentrations are low at the time when nitration is observed. However, mechanisms other than peroxynitrite have been recently reported to lead to nitrotyrosine. Thus, myeloperoxidase has been shown to oxidize the nitrite ion to the NO2 radical, and this is a nitrating species (47). Since myeloperoxidase is present in neutrophils and neutrophil recruitment is a late event in acetaminophen toxicity, this mechanism may not be important (48). Also, nitrite may be oxidized by heme or free metals, leading to the NO2 radical (49).

Nitration of Tyrosine versus Oxidative Stress

The role of tyrosine nitration in acetaminophen toxicity was investigated using inhibitors of nitric oxide synthetase and mice that were genetically deficient in iNOS (50). A comparison of the time course for development of acetaminophen toxicity in iNOS knockout mice and wild-type mice indicated no difference in the histological development of toxicity between the two groups of mice. Serum levels of nitrate plus nitrite (a measure of NO synthesis) were increased in the wild-type mice but not in the iNOS knockout mice and analysis of liver homogenates for tyrosine nitration indicated significant levels in the wild-type mice and a decreased amount in the knockout mice, possibly as a result of endothelial NOS. It was concluded that the major murine enzyme important in tyrosine nitration under normal wild-type conditions was iNOS. Interestingly, these experiments showed that acetaminophen caused a 3-fold increase in lipid peroxidation (oxidative stress) in the iNOS knockout mice but no increase in the wild-type mice. Thus, in the wild-type mice, toxicity was accompanied by tyrosine nitration, whereas in the iNOS knockout mice, toxicity was accompanied by oxidative stress. In a subsequent study (51) was determined the effect of NOS inhibitors on acetaminophen toxicity in mice. The iNOS inhibitor aminoguanidine did not significantly alter acetaminophen toxicity, but it greatly decreased tyrosine nitration and increased lipid peroxidation. Thus, the iNOS inhibitor gave information similar to that obtained in the iNOS knockout mice. These data were interpreted to indicate that excess levels of superoxide were formed in acetaminophen toxicity. When NO is present, as in the wild-type mice, the superoxide preferentially reacts to form peroxynitrite, which nitrates proteins. In the absence of NO, superoxide leads to lipid peroxidation. These data indicate the importance of NO in the disposition of superoxide, leading to oxidative stress.

Cytokines and Other Inflammatory Mediators in Acetaminophen Toxicity

Several laboratories have reported that inflammatory cytokines are increased in acetaminophen toxicity. Blazka reported the up-regulation of TNF-α and IL-1α in the acetaminophen-treated mouse (30, 52). In addition, it was showed that selective immunoneutralization of either TNF-α or IL-1α partially decreased toxicity for a period of time. In vitro studies by Kuo showed that IL-1β caused a dose-dependent up-regulation of NO in rat hepatocytes exposed to acetaminophen (53). Consistent with these data, Hinson et al. recently found that IL-1β and NO up-regulation in the acetaminophen-treated mouse are temporally related (54). Although others have confirmed the up-regulation of TNF-α in acetaminophen toxicity (55), its role in the mediation of toxicity is somewhat controversial. TNF-α knockout mice were not protected from toxicity (56), and a recent report showed that immunoneutralization of TNF-α had no effect on toxicity (55). Studies in IL-10 knockout mice suggest that IL-10 is protective in APAP toxicity by controlling NO and iNOS formation (33). In addition, the increased susceptibility of IL-10 knockout mice to acetaminophen was associated with increased levels of TNF-α and IFN-γ. Thus, it may be that proinflammatory cytokines contribute to the toxicity, and that they are regulated by anti-inflammatory cytokines, such as IL-10 and others.

Macrophage migration inhibitory factor (MIF) is a recently described protein that has characteristics of a cytokine, a hormone, and an enzyme. It may promote the up-regulation of other pro-inflammatory cytokines, adhesion molecules, matrix metalloproteinase-2 expression, NO release, and cyclooxygenase-2 and has counter-regulatory effects on endogenous glucocorticoids (57). Bourdi et al reported that MIF was up-regulated in acetaminophen toxicity (34). Moreover, MIF knockout mice were less susceptible to acetaminophen and had decreased IFN-γ production and increased heat shock protein expression (34). Heat shock proteins are considered to be a protective mechanism against various physiologic and environmental stressors (34). In addition, cyclooxygenase-2 has been reported to be hepatoprotective in acetaminophen, possibly due to up-regulation of heat shock proteins (58).

Various chemokines have also been reported to be up-regulated in acetaminophen toxicity. Chemokines were initially recognized for their role in leukocyte recruitment. However, Lawson et al. (48) showed that neutrophils followed the development of toxicity and that administration of antibodies to β2 integrins had no effect on toxicity. Chemokine up-regulation in acetaminophen toxicity appears to be hepatoprotective. Hogaboam showed that macrophage inhibitory protein-2 (MIP-2) and other related chemokines promoted hepatocyte regeneration in acetaminophen-treated mice (31). In additional studies, viral vector delivery of MIP-2 to acetaminophen-treated mice was protective against acetaminophen toxicity (59). Studies in mice deficient in CCR2, the primary receptor for the chemokine MCP-1 (monocyte chemoattractant protein-1), showed these mice to have increased toxicity to acetaminophen and increased formation of TNF-α and IFN-γ (32). Cumulatively, these studies suggest that cytokines play complex roles in the toxicity and that alterations in the equilibrium of pro- and anti-inflammatory cytokine formation contribute to the toxicity. Chemokines appear to facilitate hepatocyte regeneration following toxicity, likely by increasing the nuclear translocation of growth-regulatory transcription factors.

Superoxide Formation and Mitochondrial Dysfunction in Acetaminophen Toxicity

Superoxide may be formed via a number of mechanisms including formation from cytochrome P450 (60) and other enzymes. The importance of activation of Kupffer cells, macrophages, or neutrophils (the so-called respiratory burst) in acetaminophen toxicity has been evaluated. This sudden excess utilization of oxygen by activated phagocytes is a result of increased activity of the enzyme, NADPH-oxidase. The result is release of superoxide anion at the outer surface of the plasma membrane (61). James et al utilized mice genetically deficient in Gp91 phox, a critical subunit of NADPH oxidase (62), and found that these mice and wild-type mice had comparable toxicity to acetaminophen. Also, both knockout mice and wild-type mice had the same degree of tyrosine nitration in the liver. An analysis of mitochondrial glutathione disulfide was found to be comparable in the two groups (62). These data suggest that the increased superoxide in acetaminophen toxicity is not from activated macrophages.

Available data suggest that mitochondrial dysfunction may be an important mechanism in acetaminophen-induced hepatotoxicity. It is known that mitochondrial permeability transition (MPT) occurs with formation of superoxide, and this may be the source of superoxide leading to peroxynitrite and tyrosine nitration. MPT represents an abrupt increase in the permeability of the inner mitochondrial membrane to small molecular weight solutes. Oxidants such as peroxides and peroxynitrite, Ca2+, and Pi promote the onset of MPT, whereas Mg2+, ADP, low pH, and high membrane potential oppose onset. Associated with the permeability change is membrane depolarization, uncoupling of oxidative phosphorylation, release of intramitochondrial ions and metabolic intermediates, and mitochondrial swelling. MPT mechanisms have been reviewed by Lemasters et al. (63). In the late 1980s it was shown that cyclosporin A specifically blocked the onset of MPT in a saturable manner, implying a protein channel or pore. It has been subsequently recognized that this pore transports both anionic and cationic solutes of mass less than 1500 Da and is the previously identified multiple conductance channel. Of particular note is the fact that oxidation of vicinal thiols in the pore promote an open conductance state (63). Addition of NAPQI to isolated rat liver mitochondria caused a decrease in synthesis of ATP and an increase in release of sequestered Ca2+. This release was blocked by cyclosporin A (20). These data are consistent with the hypothesis that NAPQI causes MPT, as has been reported about other quinones (64). This is presumably a result of NAPQI-mediated oxidation of the vicinal thiols at the MPT pore. NAPQI is known to be both an oxidizing agent and an arylating agent, and Tirmenstein and Nelson (13) have reported that acetaminophen leads to oxidation of protein thiols. Also, McLean and coworkers have reported that inhibitors of MPT decrease acetaminophen toxicity in rat liver slices and in vivo (65). Lastly, Grewal reported that late addition of N-acetylcysteine to freshly isolated mouse liver hepatocytes had no effect on the toxicity; however, dithiothreitol decreased the further development of toxicity (66). Also, in similar experiments with isolated hamster hepatocytes, the late addition of dithiothreitol to cells washed free of acetaminophen prevented the further decrease in cell viability and appeared to reverse morphological changes (67). Dithiothreitol is known to reduce the vicinal thiols at the MPT pore and prevent the further progression of toxicity (64). These data are consistent with a mechanism whereby acetaminophen toxicity is by NAPQI-mediated oxidation of thiol groups in mitochondria leading to MPT. The toxicity is mediated by mitochondrial dysfunction resulting in production of reactive oxygen/nitrogen species.

Summary

With the analgesic acetaminophen it was shown that the hepatic necrosis was not a result of the parent compound. Metabolism by cytochrome P450 enzymes to a reactive metabolite was necessary for the production of toxicity. After therapeutic doses of acetaminophen, the reactive metabolite was efficiently detoxified by conjugation with GSH. However, after toxic doses, GSH was depleted by the conjugation reaction and the metabolite covalently bound to protein. Covalent binding correlated with development of toxicity. Treatment with cysteine to increase GSH detoxification was shown to be an effective antidote against toxicity. The latter finding led to the development of N-acetylcysteine as the current clinical antidote. Since these initial findings, many investigators have added additional details relative to the concept of how acetaminophen is toxic, and some of these are discussed in this review. Despite these recent studies, the concept of metabolic activation as the critical initiating event in the development of toxicity has remained. Moreover, metabolic activation has proven to be a general mechanism relevant for the development of toxicity for many drugs and chemicals.

Abbreviations

NAPQI, N-acetyl-p-benzoquinone imine; GSH, glutathione; IL, interleukin; TNF-α, tumor necrosis factor- ; NO, nitric oxide; iNOS, inducible nitric oxide synthase; IFN-γ, interferon-γ; MIF, macrophage migration inhibitory factor; MPT, mitochondrial permeability transition.

Correspondence to

Dr. Agni D. Grypioti, Department of Pharmacology, Medical School, University of Athens, Mikras Asias 75, 115 27, Athens, Greece. E-mail: agrypiot@med.uoa.gr

References

1. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Cobaugh DJ, Youniss J, Omslaer JC, May ME, Woolf AD, Benson BE: 2001 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20: 391-452, 2002.
2. Prescott LF: Hepatotoxicity of mild analgesics Br J Clin Pharmacol 10: 373S-379S, 1980.
3. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H: Inhibition of Fas receptor (CD95)-induced caspase activation and apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 156: 179-186, 1999.
4. Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H: Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67: 322-328, 2002.
5. Bessems JG and Vermeulen NP: Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31: 55-138, 2001.
6. Nelson SG, Wan Z, Stan MA: S(N)2 ring opening of beta-lactones: an alternative to catalytic asymmetric conjugate additions. J Org Chem 67: 4680-4683, 2002.
7. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211-217, 1973.
8. Dahlin DC, Miwa GT, Lu AY, Nelson SD: N-Acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81: 1327-1331, 1984.
9. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS: Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6: 511-518, 1993.
10. Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT: Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 45: 1563-1569, 1993.
11. Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, Nelson SD: Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol 11: 295-301, 1998.
12. Nelson SD: Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 10: 267-278, 1990.
13. Tirmenstein MA and Nelson SD: Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. J Biol Chem 264: 9814-9819, 1989.
14. Tsokos-Kuhn JO, Hughes H, Smith CV, Mitchell JR: Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. Biochem Pharmacol 37: 2125-2131, 1988.
15. Cohen SD and Khairallah EA: Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 29: 59-77, 1997.
16. Pumford NR, Halmes NC, Martin BM, Cook RJ, Wagner C, Hinson JA: Covalent binding of acetaminophen to N-10-formyltetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther 280: 501-505, 1997.
17. Qiu Y, Benet LZ, Burlingame AL: Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 273: 17940-17953, 1998.
18. Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB: Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 7: 453-463, 1993.
19. Salas VM and Corcoran GB: Calcium-dependent DNA damage and adenosine 3',5'-cyclic monophosphate-independent glycogen phosphorylase activation in an in vitro model of acetaminophen-induced liver injury. Hepatology 25: 1432-1438, 1997.
20. Weis M, Kass GE, Orrenius S, Moldeus P: N-Acetyl-p-benzoquinone imine induces Ca2+ release from mitochondria by stimulating pyridine nucleotide hydrolysis. J Biol Chem 267: 804-809, 1992.
21. Donnelly PJ, Walker RM, Racz WJ: Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Arch Toxicol 68: 110-118, 1994.
22. Coles B, Wilson I, Wardman P, Hinson JA, Nelson SD, Ketterer B: The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys 264: 253-260, 1988.
23. Nakamura W, Hosoda S, Hayachi K: Purification and properties of rat liver glutathione peroxidase. Biochim Biophys Acta 358: 251-261, 1974.
24. Dai Y and Cederbaum AI: Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 273: 1497-1505, 1995.
25. de Vries J: Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilate: oxygenation or electron transfer? Biochem Pharmacol 30: 399-402, 1981.
26. Nakae D, Yoshiji H, Yamamoto K, Maruyama H, Kinugasa T, Takashima Y, Denda A, Konishi Y: Influence of timing of administration of liposome-encapsulated superoxide dismutase on its prevention of acetaminophen-induced liver cell necrosis in rats. Acta Pathol Jpn 40: 568-573, 1990.
27. Sakaida I, Kayano K, Wasaki S, Nagatomi A, Matsumura Y, Okita K: Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. Scand J Gastroenterol 30: 61-67, 1995.
28. Schnellmann JG, Pumford NR, Kusewitt DF, Bucci TJ, Hinson JA: Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicol Lett 106: 79-88, 1999.
29. Laskin DL, Gardner CR, Price VF, Jollow DJ: Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050, 1995.
30. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI: Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43-52, 1995.
31. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lukacs NW, Colletti LM, Simpson KJ, Strieter RM, Kunkel SL: Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J 13: 1565-1574, 1999a.
32. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Matsukawa A, Gosling J, Boring L, Charo IF, Simpson KJ, Lukacs NW, Kunkel SL: Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol 156: 1245-1252, 2000.
33. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR: Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298, 2002a.
34. Bourdi M, Reilly TP, Elkahloun AG, George JW, Pohl LR: Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. Biochem Biophys Res Commun 294: 225-230, 2002b.
35. Goldin RD, Ratnayaka ID, Breach CS, Brown IN, Wickramasinghe SN: Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity. J Pathol 179: 432-435, 1996.
36. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA: Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30: 186-195, 1999.
37. Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, Pohl LR: Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 15: 1504-1513, 2002.
38. Hinson JA, Pike SL, Pumford NR, Mayeux PR: Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol 11: 604-607, 1998.
39. Kaur H and Halliwell B: Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350: 9-12, 1994.
40. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge GL, Laskin JD, Laskin DL: Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 27: 748-754, 1998.
41. Pryor WA and Squadrito GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268(Pt 1): L699-L722, 1995.
42. Beckman JS and Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad and ugly. Am J Physiol 271: C1424-C1437, 1996.
43. Rubbo H: Nitric oxide and peroxynitrite in lipid peroxidation. Medicina 58: 361-366, 1998.
44. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250, 1991.
45. Sies H, Sharov VS, Klotz LO, Briviba K: Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272: 27812-27817, 1997.
46. Whiteman M, Kaur H, Halliwell B: Protection against peroxynitrite dependent tyrosine nitration and alpha 1-antiproteinase inactivation by some anti-inflammatory drugs and by the antibiotic tetracycline. Ann Rheum Dis 55: 383-387, 1996.
47. Davis KL, Martin E, Turko IV, Murad F: Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41: 203-236, 2001.
48. Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H: The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54: 509-516, 2000.
49. Thomas DD, Espey MG, Vitek MP, Miranda KM, Wink DA: Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2- reaction. Proc Natl Acad Sci USA 99: 12691-12696, 2002.
50. Michael SL, Mayeux PR, Bucci TJ, Warbritton AR, Irwin LK, Pumford NR, Hinson JA: Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide 5: 432-441, 2001.
51. Hinson JA, Bucci TJ, Irwin LK, Michael SL, Mayeux PR: Effect of inhibitors of nitric oxide synthase on acetaminophen-induced hepatotoxicity in mice. Nitric Oxide 6: 160-167, 2002.
52. Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI: Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 24: 181-189, 1996.
53. Kuo PC, Schroeder RA, Loscalzo J: Nitric oxide and acetaminophen-mediated oxidative injury: modulation of interleukin-1-induced nitric oxide synthesis in cultured rat hepatocytes. J Pharmacol Exp Ther 282: 1072-1083, 1997.
54. James LP, McCullough SS, Lamps LW, Hinson JA: Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci 75: 458-467, 2003b.
55. Simpson KJ, Lukacs NW, McGregor AH, Harrison DJ, Strieter RM, Kunkel SL: Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis. J Pathol 190: 489-494, 2000.
56. Boess F, Bopst M, Althaus R, Polsky S, Cohen SD, Eugster HP, Boelsterli UA: Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. Hepatology 27: 1021-1029, 1998.
57. Baugh JA, Bucala R: Macrophage migration inhibitory factor. Crit Care Med. 30: S27-35, 2002.
58. Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR: A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14: 1620-1628, 2001.
59. Hogaboam CM, Simpson KJ, Chensue SW, Steinhauser ML, Lukacs NW, Gauldie J, Strieter RM, Kunkel SL: Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury. Gene Ther 6: 573-584, 1999b.
60. Puntarulo S and Cederbaum AI: Role of cytochrome P-450 in the stimulation of microsomal production of reactive oxygen species by ferritin. Biochim Biophys Acta 1289: 238-246, 1996.
61. Baggiolini M and Wymann MP: Turning on the respiratory burst. Trends Biochem Sci 15: 69-72, 1990.
62. James LP, McCullough SS, Knight TR, Jaeschke H, Hinson JA: Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress. Free Radic Res, 37: 1289-97, 2003a.
63. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B: The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177-196, 1998.
64. Palmeira CM and Wallace KB: Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicol Appl Pharmacol 143: 338-347, 1997.
65. Beales D and McLean AE: Protection in the late stages of paracetamol-induced liver cell injury with fructose, cyclosporin A and trifluoperazine. Toxicology 107: 201-208, 1996.
66. Grewal KK and Racz WJ: Intracellular calcium disruption as a secondary event in acetaminophen-induced hepatotoxicity. Can J Physiol Pharmacol 71: 26-33, 1993.
67. Tee LB, Boobis AR, Huggett AC, Davies DS: Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiothreitol. Toxicol Appl Pharmacol 83: 294-314, 1986.

Author Information

A. D. Grypioti, Ph.D.
Department of Experimental Pharmacology, Medical School, National and Kapodistrian University of Athens

Your free access to ISPUB is funded by the following advertisements:

Advertisement